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Background: Non-adherence to TB treatment poses a major challenge to Tuberculosis (TB) control 
programs because it increases the risk of treatment failure, relapse and the emergence of drug resistant 
tuberculosis.  
Aim: The study aimed to describe socio-cultural and behavioral factors affecting adherence to TB 
treatment in Malawi. 
Methods: A cross-sectional and mixed methods study design was used. A simple random sample of 200 
participants who were on TB treatment at the time of the study and were getting their TB drugs from 
Bwaila hospital, in Lilongwe District, Malawi was selected. A pretested and structured questionnaire and 
Focus Group Discussions were used to collect data. Data were entered and analyzed using Microsoft 
excel. Focus Group Discussions data were subjected to a thematic content analysis. 
Results: The majority of the respondents had ever heard about TB before being diagnosed with the 
disease (77.5%) and the most frequent source of information about TB was from friends, relatives and 
workmates (45.5%). 95.5% of the respondents disclosed their TB status to others and 90.0% of the 
respondents did not perceive having TB as shameful. 88.5% of the respondents reported taking their TB 
medication according to guidelines. While 88.5% of respondents reported that there were no barriers that 
prevent TB patients from adhering to their TB medication, the following barriers were reported by other 
respondents: travelled without medication (3.5%), forgetfulness (2.5%), long travel distance to health 
facility (2.5%), didn’t understand dose instructions (1.5%). 
Conclusions: This study found that TB patients who have the correct knowledge and information about 
TB and its treatment are more likely to adhere to treatment than those who have no knowledge about TB, 
and that having TB is not self-stigmatized and shameful. Despite the fact that most of the respondents 
reported facing no barriers preventing them from adhering to TB treatment, there were some reported 
barriers that prevent TB patients from adhering to treatment. There is a need therefore to address these 









CHAPTER ONE.  INTRODUCTION AND LITERATURE REVIEW 
1.1 INTRODUCTION 
Tuberculosis is an ancient disease, affecting humans throughout history. Robert Koch discovered its 
causative agent in 1882 and in 1944, the first anti-TB drug, Streptomycin, was discovered (1).  
Tuberculosis is an airborne disease caused by the bacterium Mycobacterium tuberculosis (M. 
tuberculosis). M. tuberculosis organisms are also called tubercle bacilli. The disease is spread via 
infectious droplet nuclei (1-5 microns in diameter) which are generated when persons who have 
pulmonary TB disease cough, sneeze, shout or sing. Depending on the environment, these tiny particles 
can remain suspended in the air for several hours. Transmission occurs when a person inhales droplet 
nuclei containing M. tuberculosis (2). It is estimated by the World Health Organization (WHO) that in 
2018, 10.0 million people fell ill with TB globally with an estimated 1.2million TB deaths among HIV- 
negative people and an additional 251,000 deaths among HIV-positive people (3).  
  
Malawi is one of the developing countries in Sub-Saharan Africa faced with many Tuberculosis (TB) 
health-related challenges. TB is considered a major public health problem accounting for one of the top 
ten killer diseases in the country and in 2007 Malawi declared TB as a national emergency in order to 
raise awareness and improve TB case detection (4) .  In 2013, 20,335 new and relapse cases and 1,400 TB 
deaths were reported in Malawi (5).  The national TB prevalence survey completed in 2014 showed a 
higher TB prevalence of 1014/100,000 compared to the previous estimated prevalence of 373/100,000 by 
the World Health Organization (6).  
 
According to statistics in Malawi, TB treatment success rate was at 82% in 2016. Since then the number 
has steadily increased to 88% in 2018 (5) .  
Adherence is defined by WHO as “the extent to which a person’s behavior- taking medication, following 
a diet, and or executing lifestyle changes, corresponds with agreed recommendations from a health care 
provider” (8). The use of the concept of adherence is important in that it conveys a partnership between 
patient and physician. It also allows for a more comprehensive assessment of factors related to adherence 
such as characteristics of the regimen, attitudes of the providers, socio-economic, cultural and 
environmental factors (8).   
 
It is important to note the difference between the concepts adherence and compliance. In compliance, the 
guidelines given by physicians are assumed to be accurate and patient responses to treatment are 




in the event of suboptimal treatment responses. As the article explains, the term also exaggerates patient 
agency, as it suggests that all patients possess the ability to comply- or refuse to comply with anti-TB 
treatment, which it explains is far from true. According to the article “the poor are victims of structural 
violence, which includes factors such as poverty, racism and gender inequality which affects them from 
the time of exposure to the disease all the way up to their access to health care” (9).Therefore while 
addressing adherence we should not only address factors directly related to the patient but also the 
aforementioned factors related to structural violence, since as the article notes: “although adopting a 
patient-centered approach is important, it is nevertheless insufficient”. The challenge to researchers is to 
acknowledge that adherence is influenced by a complex array of factors, many of which are beyond the 
patient’s control, and to begin identifying and describing these factors. Adherence to long term therapy 
for chronic illnesses in developed countries averages 50%, with rates possibly being lower in developing 
countries (9). 
 
Despite the magnitude and potential gravity of suboptimal medication adherence, a gold standard 
intervention remains elusive; a recent Cochrane review highlighted the paucity of effective interventions 
in current practice (10). Evidence suggests that complex, multifaceted interventions tailored to meet 
individual needs are most likely to be efficacious. Which is understandable given the complex, multistage 
process that is taking medication. 
Having looked at the difference between compliance and adherence, it is important to note that in our 
study we were focusing on adherence and not compliance because adherence is not only influenced by 
patient related factors but by a number of other factors some of which are cultural and social so this study 
is hoping to contribute to determining those factors and coming up with interventions. 
 
Non-adherent behavior is traditionally categorized into unintentional and intentional. Unintentional non-
adherence includes behaviours arising from forgetfulness, misunderstanding and confusion. Intentional 
non-adherence describes patient choice that deviates from the prescribed medication regimen (10). 
Unintentional and intentional non-adherence are not mutually exclusive; thus an amalgam of these 
behaviours often exist in any one patient. An understanding of patient behavior and its underpinning 
psychology plus the wealth of factors, both internal and external that may influence medication taking is 
crucial to understand how to change patient behavior and thus improve medication adherence (10). 
 
Historically, adherence interventions have encompassed behavior change techniques such as simplifying 
dosage regimens and providing adherence aids or education to address the practical issues of adherence in 
terms of knowing how and being able to take the medication as prescribed. Pooled data for such studies 




healthcare provision. These interventions may have particularly poor efficacy in cases of intentional non-
adherence as the provision of persuasive advice may evoke further resistance to change (10). Thus, there 
has been a paradigm shift from the former adherence interventions premised on behaviour change to a 
novel approach premised on cognitive behaviour change techniques (CBCT). 
 
Through an understanding of the challenges faced in changing behaviors and the motivation necessary to 
achieve change, novel cognitive based behavior change techniques (CBCT) have emerged. These 
interventions aim to change a patient’s behavior by altering thoughts, feelings, confidence or motivation 
to adhere. CBCT interventions can vary widely in content such as incorporating techniques to enhance 
patient sense of self-efficacy, problem solving and increase motivation to adhere (10).  
Treatment adherence is a process which needs to be fully understood in order to establish its determining 
factors (11). In order to control TB, effective treatment, as well as a clear understanding of the complex 
factors that undermine adherence is required.  Most TB treatment regimens are long and patients fail to 
adhere to such long treatment regimens. The risk of treatment failure and the emergence of drug resistant 
TB are exacerbated by non-adherence to tuberculosis treatment. This poses as a challenge in the global 
fight against TB (12).  
The impacts of non-adherence are many, including poor treatment outcomes and increased health-related 
costs. Additional consequences, of public health importance, occur with infectious diseases such as TB. 
Non-adherence to TB treatment might lead to an increased risk of drug resistance and a prolonged 
infectiousness, in addition to relapse and death. This in turn will have implications not only for the patient 
but also for the community at large. 
1.2 LITERATURE REVIEW 
Tuberculosis is an ancient disease, affecting humans throughout history. Robert Koch discovered its 
causative agent in 1882 and in 1944, the first anti-TB drug, Streptomycin, was discovered (1).  
Tuberculosis is an airborne disease caused by the bacterium Mycobacterium tuberculosis (M. 
tuberculosis). M. tuberculosis organisms are also called tubercle bacilli. The disease is spread via 
infectious droplet nuclei (1-5 microns in diameter) which are generated when persons who have 
pulmonary TB disease cough, sneeze, shout or sing. Depending on the environment, these tiny particles 
can remain suspended in the air for several hours. Transmission occurs when a person inhales droplet 
nuclei containing M. tuberculosis (2).   
Adherence is defined by WHO as "the extent to which a person's behavior; taking medication, following a 
diet, and/or executing lifestyle changes, corresponds with agreed recommendations from a health care 




Poor adherence to treatment of chronic diseases including TB is a worldwide problem of striking 
magnitude. However, patients with TB are expected to have adherence levels greater than 90% in order to 
ensure cure. Failure of cure increases the risk of development of drug-resistant strains and spread of TB in 
the community, and this in turn increases morbidity and mortality (8).  
In Southern Africa, tuberculosis remains a major public health concern with a huge economic impact in 
the region. Despite the global progress made in tackling TB, the burden is still unacceptably high in 
Southern Africa. The region has the highest per capita burden of TB; with countries such as Lesotho and 
Mozambique bearing the brunt of the disease, with one of the world’s highest TB incidence at 
665/100,000 and 551/100,000 population respectively (13). Indications by the World Health Organization 
shows that in 2017 alone 49,000 and 78,000 TB deaths occurred in Mozambique and South Africa 
respectively. The high burden of disease in the region is compounded by the high HIV/AIDS burden and 
intra-regional movement of people for labour and other economic activities facilitating cross-border 
movement of the disease (13). 
One study that was conducted in 2018 in Jayapura Papua province in Indonesia on factors associated with 
non-adherence during tuberculosis treatment among patients treated with directly observed therapy  
strategy (DOTS) identified several factors related to non-adherence to TB treatment which included 
younger age, a family history of TB treatment, difficulties in accessing health care (i.e. distance/cost) and 
a history of moving residence in the past year which were all independent risk factors for non-adherence 
during TB treatment (14) In addition, treatment experience including the use of loose drugs versus fixed 
dose combination (FDC), having received any education from TB nurses and TB knowledge (cause of 
TB, how TB is transmitted and the consequence of incomplete TB treatment) were also significant risk 
factors associated with poor adherence or loss to follow up (LTFU) (14) 
Similarly, another study that was conducted in southern Ethiopia on assessment of Anti-TB drug non 
adherence and associated factors among TB patients attending TB clinics in Arba Minch governmental 
health institutions also found out that one of the factors that contributes to non-adherence to anti-TB drugs 
among TB patients is distance to the health facility. The further away the health facility is; the less likely 
TB patients are to adhere to their treatment. Other factors that were identified in this study as having an 
effect on anti-TB drug non-adherence were side effects of the drugs and waiting time at the health facility 
with longer waiting time being a contributing factor for treatment non-adherence (15).  
A study on non-adherence of new pulmonary tuberculosis patients to anti-tuberculosis treatment found 
out that one of the risk factors for non-adherence is lack of knowledge of importance of regular anti-
tuberculosis treatment. Adherence to anti-tuberculosis treatment is improved by correct knowledge about 




routes and familiarity with the availability of cure (16). This study is in line with findings from another 
study which also depicted lack of or poor knowledge about TB as one of the contributing factors to 
treatment non adherence (17). Non-adherent patients are found to have less or no knowledge about TB 
and its treatment. Knowledge and health awareness and treatment seeking behavior of an individual are 
increased by education overall. Individuals who are literate are more likely to complete the treatment. 
Underutilization of TB services, delay in seeking diagnosis and poor treatment adherence are caused by 
lack of knowledge about the disease and stigmatization. Non adherence to treatment often results from 
inadequate knowledge or understanding of the disease and its treatment (18).  
The study further found that another risk factor associated with treatment non-completion was poor 
awareness especially about symptoms and treatment results and consequence (18). Similarly, in China a 
study among internal migrants with pulmonary Tuberculosis revealed that lack of knowledge about TB 
treatment among TB patients was one of the most significant factors predicting non-adherence (17). As 
Muture B.N et al in their article note that an individual’s health seeking behavior and adherence to 
treatment is influenced by a number of factors including knowledge attitudes and perceptions. The article 
further explains that one of the risk factors that determine default from treatment is poor knowledge about 
TB treatment (19). On knowledge and attitudes, all the articles are in line with their findings that 
knowledge about TB and its treatment plays a very big role in adherence with poor knowledge resulting 
in poor adherence. There have been no such reviews or studies done in Malawi and that served as a basis 
for conducting the study. 
A 2008 literature review assessing the impact of medication regimen on adherence to chronic treatment, 
gave the following findings, although the authors underline the fact that it was difficult to obtain quality 
studies for the review (20). The authors mention that several factors have been identified as correlates of 
adherence to long term medication regimens and include patient factors such as depression, health 
literacy, and substance use disorders, environmental or contextual factors such as social support and 
socioeconomic status, clinician factors such as clear communication and the time spent explaining the 
disease and treatment, patient clinician relationship factors like trust, disease factors such as chronicity, 
symptom prominence, response to treatment, health care delivery factors such as waiting time, pharmacy 
and clinic convenience, and treatment regimen factors such as pill burden, regimen complexity, side 
effects, duration of needed treatment and dosing schedule (20) In addition, the review showed that in most 
areas of chronic illness study, there is some evidence that greater dosing frequency is associated with 
poorer adherence. In some areas such as diabetes, hypertension, HIV/AIDS, strong and consistent 
evidence exists that dose frequency and regimen complexity are related to poorer adherence. The authors 





Understanding of the factors that prevent people from adhering to treatment and those factors that help in 
treatment completion is one of the key factors that will help in improving treatment outcomes and 
designing effective interventions (21). In Sub-Saharan Africa there are some patient-related factors that 
influence default from treatment such as; older age, the male sex, inadequate knowledge, ignorance on 
need for treatment compliance and stigma (21). Tuberculosis is a disease which can be cured if patients 
strictly adhere to treatment but despite this fact, a lot of patients fail to complete their treatment because 
of the side effects that are associated with the anti-TB drugs (14).  
In most cases of non-adherence to TB medication therapy it has been found that there are several factors 
that contribute to non-adherence some of which are factors related to the patients such as discontinuation 
of medication after feeling better, forgetfulness and side effects.  There are other factors like fear of 
stigma, long travel distance to the nearest health facility that have also been reported to contribute to non-
adherence to TB medication therapy (11). Structural factors which include poverty and gender 
discrimination, social context factors, health service factors and personal factors which include attitudes 
towards treatment and illness are some of the factors that were identified to have an influence on 
adherence to TB treatment (20). Patients’ knowledge about TB and its treatment alone is not enough to 
improve adherence to TB treatment and ensure that patients complete their treatment but efforts should 
rather be focused on supporting the patients and enabling them to overcome treatment barriers (21). 
A systematic review conducted in Ethiopia on prevalence and determinants of anti-tuberculosis treatment 
non-adherence linked forgetfulness, fear of side effects of the drug, long waiting time in health 
institutions and long distance to health institution as significant factors predicting non-adherence (22). 
These findings are in agreement with another study conducted in Northwest Ethiopia in which they also 
found that drug side effects, forgetting to get medication among other factors were the main reasons for 
non-adherence in anti-TB treatment (23).  
Many factors may lead to poor completion rates. On the surface, it appears that treatment outcomes for 
TB patients are an indication of the quality of care they receive. However, various authors have 
acknowledged that the complex interactions of a wide range of personal, socio-economic and 
infrastructural factors determine patient behavior. In fact, TB may not be cured and may recur in patients 
who do not take their medications for the full treatment period. These patients may also become resistant 
to the drugs, and drug-resistant TB may then be transmitted to other persons (9). Drug-resistant TB is 
difficult and expensive to treat. Thus, the most important step to prevent drug-resistant disease is to 
ensure that patients are cured at the first attempt. This threat of TB has provided a major momentum into 
the study of factors that determine patients’ treatment adherence. For perhaps the first time, the world is 




(9). According to the WHO report on adherence to long term therapies, adherence is influenced by several 
factors simultaneously. The ability of patients to follow treatment plans in an optimal manner is 
frequently compromised by more than one barrier. Adherence is a dynamic process that needs to be 
followed up. Improving adherence requires a continuous and dynamic process. Adherence requires a 
multidisciplinary approach which means that emphasis should not only be put on the patient but on the 
health workers, the family and the community as well if adherence is to be improved (9). 
Over the years a number of strategies have been introduced to improve treatment adherence. These 
include Directly observed therapy (DOT), which until recently was endorsed by the WHO, the provision 
of free TB diagnostic and treatment services, the packaging of TB medicines in blister packs in 
individualized boxes and more recently the use of mHealth and wisepill boxes Direct observation and 
supervision of patients is assumed to be more effective than self-administration to ensure that patients 
successfully complete the recommended six-to-nine-month chemotherapy (28). Weekly distribution of 
medicines is intended to be a more effective method than monthly distribution to induce adherence. The 
provision of free diagnosis and medicines aims to eliminate costs that deter patients from seeking care and 
completing treatment. Packaging medicines in blisters and storing them in individualized boxes aims to 
facilitate correct intake and adherence. Recent studies seem to support the rationale behind those 
decisions. For example, treatment completion rates are higher among patients with direct supervision 
rather than among those with no supervision (9). 
Several ongoing national and global initiatives that are part of TB control programs also aim to address 
behavioral challenges. Programs that offer enablers such as transportation and food subsidies for patients 
assume that by minimizing costs the numbers of patients seeking diagnosis and care would increase. 
Similarly, incentive programs also assume that modifying the behaviors of health providers is necessary 
to increase treatment rates, for example, through offering monetary retributions for each patient who 
completes treatment (9). 
From a TB control point of view, informed and motivated frontline health workers may contribute to 
positive treatment outcomes (9). Conversely, de-motivated and ill-informed health workers may 
contribute to interruptions of patients and the resulting transmission of TB in affected communities. This 
study has revealed some important dysfunctional aspects of attitudes of health care providers to TB 
patients (9). According to the study, non-compliancy may result from differing interests or expectations of 
the patient and health care provider. Misperceptions or dissatisfaction with the patient-health care 
provider relationship may also be a cause of non-compliance. Indeed, the health provider-patient 




As Mekonnen explains that, adherence to long course tuberculosis treatment is complex, dynamic 
phenomenon with wide range of factors impacting on treatment taking behaviors (24) 
Different control strategies have been adopted to fight against TB and to meet the above-mentioned 
targets. One such strategy is the Directly Observed Treatment, Short Course (DOTS) strategy, launched 
by WHO in 1994. After further subsequent expansion and clarification, the framework has been 
implemented in 182 countries (25). Major progress in TB control has been achieved with the expansion of 
DOTS which has also helped national TB programs, although the targets for TB control have not yet been 
met in every corner of the world. The five major components of this Strategy are: political commitment 
with increased and sustained financing, case detection through quality assured bacteriology standardized 
treatment with supervision and patient support, effective drug supply and management system, 
monitoring and evaluation system and impact measurement (25). 
 
One of the most important components of the DOTS strategy is the direct observation of treatment 
(DOT), which implies that the patient should be supervised while taking treatment, most often by a health 
worker. DOT’s purpose is to ensure that patients take the correct treatment regularly (to achieve cure and 
prevent development of drug resistance); to find out quickly when a dose has been missed by a patient, in 
order to find out why that happened and to try and solve it; and to monitor any disease or treatment 
associated problem e.g. side effects (25). It is necessary to ensure that supervision is done in a patient 
sensitive and contextualized manner and that it is aimed to enhance adherence among both patients and 
providers. In addition, identifying physical, financial, social and cultural barriers to TB treatment is very 
important to ensure proper patient support (25). The HIV epidemic has challenged DOTS as the sole 
strategy for TB control in Africa, because of the rising incidence of TB related to high HIV prevalence 
(25). 
 
In Sub Saharan Africa, TB cases have markedly increased as a consequence of the HIV epidemic (26). 
According to a review of compliance to anti tuberculosis treatment and risk factors for defaulting 
treatment in Sub Saharan Africa, it was found that distance from the hospital, not being on the first course 
of TB medication, lack of repeated smears, unit transfer after the intensive phase, experiencing side 
effects, having no family support, poor knowledge about TB treatment, being more than 25 years old and 
use of public transport were some of the risk factors for defaulting treatment (26).  
 
Most of the studies that have been conducted on determinants of TB treatment adherence have cited lack 
of or poor knowledge about TB treatment, experiencing drug side effects and long travel distance to 




One of the main reasons for treatment default is knowledge. Studies in India, Swaziland, Thailand and 
Zambia (9) indicate that poor knowledge about the length of treatment predicts default behavior. Most 
defaulting patients interrupt treatment soon after they feel better and/or around two months after initiating 
chemotherapy. For example, findings from India suggest that patients’ misconception of well-being with 
cure leads to default. Also, patients who did not know about potential side effects of medicines were more 
likely to default (9). 
External constraints are also predictors of adherence. A study in Ethiopia (9) found that default is higher 
among patients who need longer travel distances to health center and pay for consultation (9). In 
Thailand, findings suggest that patients who cannot cope with the economic costs associated with 
treatment adherence (e.g. paying for transportation to go to clinics) are more likely to default. Besides 
poor knowledge, poverty largely accounts for default in Zambia: patients lack means to travel to the 
hospital and pay for consultation coupled with lost income for clinic attendance (9).  
It is evident from the literature review that adherence to anti-Tuberculosis treatment is influenced by a 
number of factors some of which are patient related for example lack of or poor knowledge about TB and 
its treatment, experiencing side effects and forgetting to take medication while others maybe be socio-
economical, infrastructural and cultural. This study hopes to determine such factors among TB patients in 
Malawi and also demonstrate how they influence adherence to TB treatment.  
1.3 PROBLEM STATEMENT 
 
Internationally, adherence to treatment for tuberculosis is recognized as a key principle of the TB 
elimination framework within low incidence countries, yet little is known of the personal, social and 
cultural factors that drive non-adherence across different groups in these settings. Poor adherence is cited 
as the primary reason for suboptimal clinical benefit and leads to poorer clinical outcomes, the 
development of drug resistance, increased duration of infectivity and consequent onward transmission of 
infection (27) 
According to statistics in Malawi, TB treatment success rate was at 82% in 2016. Since then the number 
has steadily increased to 88% in 2018.  On the other hand, the incidence is at 131/100,000 population (7). 
Poor adherence to treatment of chronic diseases including TB is a worldwide problem of striking 
magnitude. However, patients with TB are expected to have adherence levels greater than 90% in order to 
facilitate cure. Failure of cure increases the risk of development of drug-resistant strains and spread of TB 
in the community, and this in turn increases morbidity and mortality (15) 
 
However, very little is known about social-cultural and behavioral factors that have the potential to 




cognitive based behavior change techniques, if full adherence is to be achieved the focus must be on 
changing the patient’s behaviour by altering thoughts, feelings, confidence or motivation to adhere.  
The interventions can vary widely in content such as incorporating techniques to enhance patient sense of 
self-efficacy, problem solving and increase motivation to adhere, taking into account attendant social and 
cultural factors. This study therefore intends to explore the socio, cultural and behavioral factors that 
contribute and affect adherence to TB treatment among TB patients in Malawi and come up with 
recommendations on how to improve TB treatment success rates in Malawi.  
TB treatment success rate is at 88% as of 2018, the remaining 12% is high and maybe attributed to non-
adherence to treatment among other factors. As such it is critical for Malawi to interrogate the factors for 
non-adherence in order to inform holistic measures and strategies for addressing the problem of non-
adherence and in turn increase the TB treatment success rate.   
1.4 AIMS AND OBJECTIVES 
The study aimed at describing socio-cultural and behavioral factors affecting adherence to TB treatment 
in Malawi.  
The study had the following objectives: 
1. To describe socio-cultural attitudes with the potential to influence adherence to TB treatment 
among TB patients through the use of focus group discussions (FGDs) 
2. To determine TB patients’ knowledge of TB and its treatment through the use of a structured 
questionnaire 
3. To identify practices among TB patients with the potential to affect TB treatment adherence 
through the use of a questionnaire 
1.5. RESEARCH QUESTIONS 
1. What socio-cultural attitudes have the potential to influence adherence to TB treatment among 
TB patients in Malawi? 
2. What is the TB patients’ knowledge of TB and its treatment in Malawi?  
3. What practices among TB patients have the potential to affect TB treatment adherence in 
Malawi? 
1.6. LAYOUT OF THE THESIS 




Chapter one offers a preamble to the study and is entitled Introduction and literature Review. It discusses 
the introduction to the study, background of the study, literature review, problem statement, aim of the 
Study, research objectives, research questions and layout of the thesis. This chapter one serves an 
important role in conveying information about the research.  
Chapter Two discusses study area, research design, methodology and sample and sampling procedures, 
data collection, ethical consideration and all elements associated with design and methodology of the 
research. 
Chapter Three presents the major findings from the questionnaires, which is mainly presented in graphs 
and tables.  
Chapter Four analyses the major findings from the questionnaires and FGDs. 
 Chapter five provides a summary of what the study has established, this leads to the conclusion and 
recommendations made on the basis of the findings and analysis of the research study.   
CHAPTER 2. RESEARCH DESIGN AND METHODOLOGY 
2.1 STUDY SETTING 
The study was conducted at Bwaila hospital which is situated in Lilongwe District, the capital city of 
Malawi. It is a 255 bed facility which serves a catchment population of 164,856 people within Lilongwe 
city. The population that it serves includes the urban, semi-urban and rural population. Apart from serving 
as a referral hospital for all facilities in Lilongwe, it also serves as a referral hospital to other populations 
outside the Lilongwe catchment area. The hospital provides the following services to both inpatients and 
outpatients: family planning; antenatal and postnatal care; maternity; Kangaroo Mother Care (KMC); HIV 
testing and counseling; Early Infant Diagnosis (EID); Anti-Retro Viral Therapy (ART); Tuberculosis 
screening; Voluntary Medical Male Circumcision (VMMC) and Laboratory services.  
This facility was selected based upon the broader population that it serves which provided the study with 
the possibility of sampling people from a diversity of back grounds in terms of the social, cultural and 
economic factors thereby allowing the study to generate much more rich data and also because it is 
centrally located in the city of Lilongwe which makes it easily accessible. 
2.2. RESEARCH METHODOLOGY 
Methodology refers to the theory of how research should be undertaken. This study used mixed method. 




with another and also to allow for a much more in-depth analysis of the study findings, so as to inform 
deeper reflective conclusions and pragmatic recommendations. 
2.3 RESEARCH DESIGN 
There are a number of research designs that a research may be able to employ. For the purpose of this 
research a cross-sectional design aimed at describing socio-cultural and behavioral factors affecting 
adherence to TB treatment in Malawi was used. 
2.4. TARGET POPULATION 
 The target population was TB patients accessing their TB drugs from Bwaila hospital. 
2.5 RESPONDENTS 
Respondents were selected from the Bwaila Laboratory (Lab) TB register which was used as the sampling 
frame. The register contains the following information: Lab serial number, date of sputum collection, 
receipt and examination, full patient’s name, sex, age, complete address, name of referring facility, reason 
for sputum smear microscopy examination, results of sputum smear microscopy examination, TB 
registration number and remarks. 
The selection of respondents was based on these inclusion criteria. The participant was an active TB 
patient on treatment and was above 18 years of age. Participants that were resident in Malawi for less than 
six months were excluded from the study. 
2.6. SAMPLING STRATEGY 
2.6.1. Sample frame and Sample Size 
 Through simple random sampling with replacement, 200 participants were selected from the Bwaila 
Laboratory TB register. 
2.7. DATA COLLECTION TOOLS 
Development of data collection tools (structured questionnaire and focus group discussions) was guided 
by objectives of the study and available literature. The data collection tools were aimed at responding to 
each objective in detail. Based on an extensive literature review, a 22-item interviewer administered 
questionnaire was developed and it was used to elicit information from respondents. The first section 
addressed demographic data of participants. Second section assessed participant’s knowledge about TB 
and its treatment. Third section explored practices and attitudes among TB patients with the potential to 
affect TB treatment adherence. The last section explored ways of promoting adherence to TB treatment. 




English (Appendix 1) and for those participants who were unable to converse in English it was 
administered in the local language of Chichewa (Appendix 4). The Chichewa responses were then 
translated back to English for data analysis.  
While the questionnaires explored individual knowledge and attitudes about TB, the focus group 
discussions were aimed at capturing broader social and cultural influences and elucidated on the socio 
behavioral practices that affect adherence to TB treatment at community level (Appendix 2). 
The FGDs were also conducted in Chichewa for those participants who were unable to converse in 
English (Appendix 5). A total of 3 FGDs were conducted and each group comprised of 6 participants and 
the sample was stratified based on age and gender. 
These tools related to each other in the sense that the demographic data from the questionnaires informed 
us which age groups and gender were more likely not to adhere to TB treatment. At the same time, they 
also informed on the level of knowledge about TB and its treatment across different age groups and 
between males and females. The focus group discussions informed on people’s beliefs, cultural norms and 
practices concerning TB and its treatment at society level. 
2.8 DATA COLLECTION PROCESS 
Eligible participants who were identified from the Laboratory TB register were contacted by telephone 
and they were informed about the study. Verbal consent was sought and after agreeing to participate in 
the study they were traced and followed to their respective homes where written consent was sought and 
secured. Following on obtaining consent from participants a questionnaire was administered in an isolated 
room to maintain privacy and to avoid disturbance from other family members. The duration of the 
questioning varied from 25 to 30 minutes. For focus group discussions (FGDs), they were conducted in 
three different areas in Lilongwe namely: Mtsiliza, Kandikole and Kaondo villages with TB patients 
accessing their TB drugs from Bwaila hospital. They were informed about the study and asked for 
consent to participate. After consenting they were put in groups comprising six to ten people and the 
sample was stratified based on age and gender. Three FGDs were conducted. The discussions run for 
approximately 45 minutes and there was a note taker who was taking notes of what was being discussed. 
The principal investigator guided the discussions. 
2.9 PILOTING AND VALIDATION 
Once the data collection tools were developed, they were piloted with five voluntary non-participants in 
order to validate if the tools were able to capture all the needed information. It also provided the 




2.10 DATA ANALYSIS 
Data was analyzed using Microsoft excel and presented through the use of tables, graphs and verbal 
descriptions. 
Qualitative data was subjected to a thematic content analysis. The analysis was done manually using 
general purpose software. Microsoft word was used for this process. 
2.11. ETHICAL CONSIDERATIONS 
The study protocol was submitted to College of Medicine research and ethics committee (COMREC) and 
BREC for ethical review and it was approved. To ensure privacy, participant’s responses to the 
questionnaire and FGDs were kept in a locked cabinet and later the data was entered in a password 
protected computer. Only the investigator, research assistant and research supervisor had access to the 
data. To ensure confidentiality, participants were only identified by code numbers throughout the study. 
A number of ethical considerations guided the study. This included: obtaining informed written consent 
from the participants whereby the purpose of the study was explained to all participants sampled to get 
their consent; explaining to the participants about their rights; and respecting the privacy of the 
participants. The respondents were assured that their participation was voluntary hence they had the right 
not to participate. An information sheet and a consent form were used to inform the participants about the 
background, the intention and confidentiality of the research. The consent form had two versions, the 
English version and the Chichewa version and was administered depending on what language the 
participant was comfortable with. (Appendix 3) The interviews were also carried out in private. 
CHAPTER 3. RESULTS 
3.1. Introduction 
Following collection of data from respondents, it was analysed using Microsoft excel and presented 
through the use of tables, graphs, and verbal descriptions. The results of the research are discussed below. 
3.2. Social demographic characteristics of the respondents. 
3.2.1. Age 
From table 3.1 below, the research has established that the majority of the participants were those aged 39 
years and above, 73 (36.5 %). While the lowest number of respondents were those aged between 18 -22 




Table 3. 1 Age distribution of the respondents 
 Frequency Percent 
 18-22 17 8.5 
23-27 27 13.5 
28-33 42 21.0 
34-38 41 20.5 
39 above 73 36.5 
Total 200 100.0 
 
3.2.2. Sex and Marital status. 
 
As shown in figure 3.1 below, the majority of participants were men 61 % (122). On marital status 
distribution, 56% (112) of the participants were married; while 44 (22%) were single; 22 (11%) were 
divorced, 14 (7%) were separated and 8 (4%) were widowed. (Refer to Table 3.2).  
 
 
Figure 3. 1 Sex of the respondents. 
Table 3. 2 Marital status of the respondents 
 Frequency Percent 
 Single 44 22.0 
Married 112 56.0 
widowed 8 4.0 
divorced 22 11.0 




Total 200 100.0 
 
3.2.3 Educational status. 
 
On the participants’ level of education, 88 participants (44%) had attended at least primary education; 86 
(43%), secondary; while only 10 (5%) had done their tertiary education (Refer Table 3.3 Below). 
 
Table 3. 3 Respondent's level of education 
 Frequency Percent 
 None 16 8.0 
primary 88 44.0 
secondary 86 43.0 
tertiary 10 5.0 
Total 200 100.0 
3.2.4. Current Occupation 



























Farmers Fisherman/woman Business person Schooling Employed None
Occupation




3.3 Participants’ knowledge about TB and its treatment. 
The majority of respondents (77.5%) had ever heard about TB before being diagnosed with the disease 
and the most frequent source of information about TB was from friends, relatives, and workmates 
representing 45.5%. 22.5% of the respondents had never heard about TB.  Only 6% of the respondents 
heard from school. (Refer to figure 3.3 & and table 3.5 below) 
 
 
Figure 3. 3 Ever heard of TB before this treatment? 
 
Table 3. 4 Source of information on TB 
Source of information on TB Crosstabulation 
Count     
  Ever heard of TB Percentage 
  Yes no  




91 0 45.5 
 
healthy workers 20 0 10 
newspapers 1 0 0.5 
Radio 24 0 12 
television 1 0 0.5 
Booklet 5 0 2.5 
School 12 0 6 
None 0 45 22.5 
Others 1 0 0.5 





3.3.1 What symptoms can show that a person has TB? 
The findings show that on symptoms of TB, “coughing for over 3 weeks”, was the most frequently 
mentioned symptom representing 50% followed by “coughing with sputum” which represented 18.5%. 
11% of the respondents claimed not knowing any symptom of TB. The results on symptoms of TB have 
been summarized in Table 3.5 below. 
 
Table 3. 5 Symptoms of TB 
Symptom Frequency Percent 
 coughing with sputum 37 18.5 
coughing for over 3 weeks 100 50.0 
periodic increase of temperature for over 3 weeks 11 5.5 
blood in sputum 2 1.0 
loss of appetite 4 2.0 
night sweating 10 5.0 
pain in the chest 11 5.5 
total weakness 1 .5 
weight loss 2 1.0 
Don't know 22 11.0 
Total 200 100.0 
 
Respondents were asked whether TB was contagious, 181 respondents answered yes representing 90.5% 
while 4% answered no and 5.5% claimed they did not know whether TB was contagious or not. (Refer to 
Table 3.7 below) 
 
Table 3. 6 Is TB Contagious? 
 Frequency Percent 
 yes 181 90.5 
no 8 4.0 
don't know 11 5.5 






Furthermore, results indicate that majority of the respondents (79%) responded that TB is transmitted 
through the air when coughing, and on the other hand 11.5% did not indicate on what they know. One 
respondent said TB is transmitted through blood. 
 
Table 3. 7 TB transmission 
 Frequency Percent 
 Through the air when coughing 158 79.0 
Through blood 1 .5 
sharing food with an infected person 5 2.5 
you're born with it 9 4.5 
Don't know 4 2.0 
Others 23 11.5 
Total 200 100.0 
 
Table 3. 8 Individuals Knowledge about TB and Adherence to TB treatment 
Ever heard of TB * Do you take your TB medication according to guidelines * How is TB 
transmitted Cross tabulation 
How is TB transmitted Do you take your TB medication 
according to guidelines 
Total 
yes no 
Through the air when 
coughing 
Ever heard of TB yes 119 12 131 
no 25 2 27 
Total 144 14 158 
Through blood Ever heard of TB no 1  1 
Total 1  1 
sharing food with an 
infected person 
Ever heard of TB yes 2  2 
no 3  3 
Total 5  5 
you're born with it Ever heard of TB yes 4 2 6 
no 2 1 3 
Total 6 3 9 
Don't know Ever heard of TB yes 2 0 2 
no 0 2 2 
Total 2 2 4 
Others Ever heard of TB yes 11 3 14 
no 8 1 9 
Total 19 4 23 
Total Ever heard of TB yes 138 17 155 
no 39 6 45 





Results indicate that all the respondents said that TB was curable representing 100%. From table 3.8 
above, and using the parameters set, it has been established that there were a total of 131 respondents who 
indicated that they have heard about TB and that TB is spread through the air when coughing. Out of 
these 131 respondents, 12(9.2%) indicated that they don’t take their drugs according to the guidelines and 
119(90.8%) indicated that they take their medication according to the guidelines.  
The study further tested if gender had an effect on the knowledge on whether patients take TB medication 
according to guidelines or not. Figure 3.4 presents a visual indication on whether the association exist or 
not. The chi-square test table confirms that there was no association between gender and patients taking 
medication according to guidelines (x2(2)>=1.822, p=0.177).  
 
Figure 3. 4 Gender against taking medication according to guidelines 
 
Table 3. 9 Chi-Square test 
 






Pearson Chi-Square 1.822a 1 .177   
Continuity Correctionb 1.260 1 .262   
Likelihood Ratio 1.911 1 .167   
Fisher's Exact Test    .256 .130 
Linear-by-Linear Association 1.812 1 .178   




a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 8.97. 
b. Computed only for a 2x2 table     
 
3.4. Practices among TB patients with the potential to affect TB treatment Adherence. 
3.4.1. Do you take your TB medication according to guidelines? 
 
The majority of the respondents, 177 (88.5) said that they take their TB medication according to 
guidelines. 
Table 3. 10 TB Medication According to Guidelines 
 Frequency Percent 
 yes 177 88.5 
no 23 11.5 
Total 200 100.0 
 
3.4.2. What are some of the challenges/barriers that prevent you from adhering to your 
medication? 
On challenges or barriers that prevent TB patients from adhering to their TB medication, the majority of 
the respondents, 177 (88.5%) said that there were none, while 3.5% said they travelled without 
medication and 2.5% cited forgetfulness.  
Table 3. 11 Barriers to medication adherence 
 Frequency Percent 
 Forgetfulness 5 2.5 
travelled without medication 7 3.5 
long travel distance to healthy facility 4 2.0 
thought that they were cured 1 .5 
too weak to travel to healthy facility for drug 
refill 
2 1.0 
None 177 88.5 
didn't understand dose instructions 3 1.5 
Others 1 .5 






3.5. Socio-cultural attitudes with the potential to influence adherence to TB treatment among TB 
patients 
3.5.1. Did you disclose your TB status to others? 
The Pie chart below shows that on TB status disclosure, 95.5% of the respondents said they disclosed 
their TB status to others while 5.0% did not disclose. A logistic regression was performed to ascertain the 
effects of education, marital status and gender on the likelihood that the results influenced participant’s 
disclosure of TB status. The results from the logistic regression shows that the variables were not 
statistically significant as the p values were greater than 0.05. 
 
Figure 3. 5 Disclose of TB Status 
 
Table 3. 12 Regression Analysis 
Variables not in the Equation 
   Score df Sig. 
Step 0 Variables Education 3.735 1 .053 
Marital status .519 1 .471 
Gender 4.252 1 .039 





3.5.2. Why didn't you disclose your TB status? 
Asked why they did not disclose their TB status to others, 95.0% of the respondents said there was no 
reason while 4.0% said people will avoid them and 1.0% said they will lose their friends. 
 
Table 3. 13 Why TB Patients do not disclose their status 
 Frequency Percent 
 I will lose my friends 2 1.0 
People will avoid me 8 4.0 
none 190 95.0 
Total 200 100.0 
 
3.5.3. Is it shameful to have TB? 
Asked whether it was shameful to have TB, 95.0% of the respondents said no while 5.0% said yes. 
 
Figure 3. 6 Is it shameful to have TB? 
 
3.5.4. Why is it shameful to have TB? 
Asked why it was shameful to have TB, 94.5% of the respondents cited no reason while 2.5% said 
because people associate it with HIV, 2.5 % of the respondents cited fear of stigma. 
 
Table 3. 14 Respondents views on TB 
 Frequency Percent 




fear of stigma 5 2.5 
None 189 94.5 
Others 1 .5 
Total 200 100.0 
 
3.5.5. What other treatment options have you sought apart from taking Anti-TB drugs? 
Findings presented on Figure 3.7 shows that 10.5% of the respondents said apart from taking anti-TB 
drugs they had also taken herbal medicine while 89.5% had not sought any other TB treatment option. 
 
 
Figure 3. 7 Other treatment option apart from Anti-TB drugs 
3.5.6. Is it a common practice to combine TB medication with other treatment options? 
Asked whether it was common to combine TB medication with other treatment options, 26.5% of 
respondents said yes while 73.0% said no and only 0.5% said they did not know. 
 
Table 3. 15 Practice of Combining TB Treatment and other Treatment options 
 Frequency Percent 
 yes 53 26.5 
no 146 73.0 




Total 200 100.0 
 
3.6. Support needed by TB patients from relatives and the community 
On support needed by TB patients from relatives and the community, the majority of the respondents, 
49.5% mentioned daily reminder to take TB medication, while 25.0% mentioned provision of food and 
only 0.5% mentioned financial support. 
 
Table 3. 16 Support needed by TB patients 
 Frequency Percent 
 Daily reminder to take TB medication 99 49.5 
provision of food 50 25.0 
help with household chores 5 2.5 
collection of TB drugs from healthy facility 12 6.0 
None 13 6.5 
not sure 7 3.5 
moral support 13 6.5 
financial support 1 .5 
Total 200 100.0 
 
3.7. Ways of promoting adherence to TB treatment 
3.7.1. What do you think the government can do to promote adherence to TB treatment? 
Asked on ways of promoting adherence to TB treatment, 24.0% of the respondents said conducting TB 
awareness campaigns while another 24.0% said provision of food supplements like soya, chiponde, milk 
and cooking oil, 12.5% mentioned supportive home visits, 9.5% mentioned availability of TB drugs in all 













Table 3. 17 promotion of TB treatment adherence by government 
 Frequency Percent 
 conducting TB awareness campaigns 48 24.0 
provision of food supplements e.g. soya, chiponde, milk, 
cooking oil 
48 24.0 
financial support 4 2.0 
physical pill count by healthy personnel 6 3.0 
supportive home visits 25 12.5 
availability of TB drugs in all heathy facilities across the 
country 
19 9.5 
not sure 23 11.5 
None 25 12.5 
Others 2 1.0 
Total 200 100.0 
3.8. Themes emerging from the Focus Group Discussions 
This section covers the findings of the Focus Group Discussions (FGDs) that were conducted in the areas 
of T/A Njewa at Mtsiliza village, T/A Tsabango at Kandikole and Kaondo villages. In summary the 
FGDs were conducted in two T/As and covering three villages. The following themes were identified 
from the FGDs: 
 Adherence to TB treatment and its challenges 
 Disclosure of TB status 
 Perception of TB as a disease 
 Use of other treatment options apart from anti-TB drugs 
 Support needed by TB patients from relatives, healthy workers and the community 
 Ways of promoting adherence to TB treatment 
3.8.1. Adherence to TB treatment and its challenges 
The research established that in the area of T/A Tsabango at both Kandikole and Kaondo villages, TB 
patients don’t take their drugs according to the guidelines. It was indicated that some TB patients in the 
said villages throw their drugs in the toilets while others miss taking their drugs because of drinking beer. 
For example, at Kandikole village one member was captured as saying, ‘‘Anthu ena amapezeka kuti  




observed taking beer and as a result they forget to take their medication due to the influence of alcohol. 
Secondly, at Kaondo village, one member was captured as saying that, anthu ena amadumphitsa kumwa 
mankhwala, ena  amataya mankhwalaku toilet.’’ ‘‘Zimadabwitsa kuti anthu ena  amadwala  chifuwa cha 
TB mobwelezabweleza chomwe chili chitsimikizo kuti samamaliza mankhwala awo’’ Meaning that some 
TB patients do not take their medication according to the guidelines and others throw the drugs in the 
toilet. It is surprising to see some people suffering from TB repeatedly, a situation which demonstrates 
that some TB patients don’t finish their dosage. 
 
The FGDs also established that TB drugs have adverse side effects, such as feeling very weak, dizziness 
and feeling hungry. These side effects were cited as some of the reasons that deter others from finishing 
their dosage. Additionally, others also indicated that the TB pills are huge in size and therefore difficult to 
swallow. The other point was that the health wellbeing of some patients improves greatly before finishing 
the dosage and as such they don’t see the need for finishing their dosage.  
3.8.2. Disclosure of TB status 
The disclosure of TB status was established to be a minor challenge. It was established that TB patients 
are able to disclose their status to their relatives and other members of the community. They felt that TB 
is just like any other disease because it can attack anyone regardless of one’s social-economic status. 
However, at Kandikole village, under T/A Tsabango one member indicated that he did not disclose his 
status because he was afraid of stigma and discrimination which would have been levelled against him 
due to his status. The respondent was captured as saying, ‘‘ndimawopa kuti ndikauza anthu ayamba 
kundisala komanso ikhala ngati nkhani yonditozera’’ 
3.8.3. Perception of TB as a disease 
In all the three villages covered, the FGDs established that it was not shameful to have TB. People in 
these areas perceived TB as any other disease and they did not feel ashamed that they were diagnosed 
with TB. 
3.8.4. Use of other treatment options apart from anti-TB drugs 
The FGDs revealed that some TB patients sought other treatment options apart from taking anti- TB 
drugs. A case in point is at Mtsiliza Village, under T/A Njewa where one member was captured as saying, 
‘‘Anthu ena amakhulupirira kwambiri mankhwala a zitsamba kuposa a chipatala pa chifukwa 
chimenechi, anthu amatha kumaphatikiza mankhwalawa.’’Meaning that some people believe in 
traditional medicine more than the conventional medicine and as such they combine the two. Secondly, at 
Kandikole village, under T/A Tsabango, it was also established that some TB patients combine the Anti-
TB drugs with herbal medicine called Teras. The respondent was captured as saying, ‘‘Ndidayesapo 




two scenarios is clear that TB patients apart from taking their anti- TB drugs also take traditional 
medicine as a supplement.  
3.8.5. Support needed by TB patients from relatives, healthy workers and the community 
 
Most members indicated that they expect their relatives to remind them consistently about the dates which 
they need to go to hospital for drug refill and also the time of taking drugs. Additionally, they also stated 
they expect their relatives to supply them with adequate food and also encourage them to eat adequate 
food since the anti- TB drugs make them feel hungry and weak. One respondent from Kandikole and 
another one from Mtsiliza stated that they expect the healthy workers to give them advice on TB and also 
to encourage them to take their TB medication according to guidelines. They also expect to be received 
with courtesy at the hospital. 
3.8.6. Ways of promoting adherence to TB treatment 
Most of the participants under this theme indicated that Government should provide them with food 
related items such as ‘‘soya flour’’, maize flour and cooking oil. For example, at Kaondo Village, under 
T/A Tsabango, one member stated as follows, ‘‘Boma likuyenera kumagawa zakudya monga chimanga 
kwa anthu omwe akumwa mankhwala a TB chifukwa timakhala ofooka ndipo sitingathe kugwira ntchito 
kuti tidzipezere chakudya.’’ Meaning that government should consider providing free food support to TB 
patients because in most cases they are weak and cannot afford to work and find food to feed themselves. 
 
Secondly, participants also indicated that government should intensify public awareness campaign 
messages about TB screening, and taking TB medication according to guidelines. Another respondent 
stated that government should make sure that there is availability of anti-TB drugs in all healthy facilities 
across the country because some TB patients travel long distances to collect anti-TB drugs only to be told 












CHAPTER 4: DISCUSSION  
4.1. INTRODUCTION 
The objective of this study was to describe the socio-cultural and behavioral factors that affect adherence 
to TB treatment in Malawi. The use of both qualitative and quantitative methods has enabled us to 
understand the factors that prevent TB patients from adhering to treatment. This chapter will discuss those 
factors in detail and ways of promoting adherence to TB treatment. Five themes emerged from the focus 
group discussions which will also be discussed in detail. 
TB patients who have the correct knowledge about TB and its treatment are more likely to adhere to 
treatment than those who have no knowledge about TB. This is actually in line with findings from other 
studies in which lack of knowledge about TB and its treatment was identified as a contributing factor to 
non-adherence (16) (18) (17). Poor knowledge about TB treatment is one of the risk factors that 
determine default from treatment (19). From our study, 77.5% of the respondents had knowledge about 
TB and 50.0% of them were able to mention at least one correct symptom of TB (coughing for over 3 
weeks). This display of knowledge can be attributed to the fact that almost half of the respondents had 
attended secondary education (43.0%). 
Majority of the respondents from our study (95.0%) felt that having TB is not a shameful thing. They felt 
that TB is just like any other disease and it can attack anyone regardless of one’s social-economic status. 
This can further be evidenced by the number of respondents who were able to disclose their TB status to 
others (95.0%). It is actually in quite contrast with findings from one study in which having TB was 
found to be a contributing factor to treatment non-adherence mainly because of fear of stigma from the 
community. Majority of the respondents in that study indicated that they would feel embarrassed and 




4.2 Implications of the themes from the Focus Group Discussions 
4.2.1. Adherence to TB treatment and its challenges 
Alcohol abuse was perceived as a major barrier to TB treatment adherence. It was indicated among the 
respondents that some TB patients miss taking their TB drugs because of recurring use of alcohol. Some 
TB patients are often seen taking beer and as a result they forget to take their medication due to the 
influence of alcohol. This is in line with findings from one study in which the recurring use of alcohol 
was found to be a factor which leads to treatment non-adherence (24). 
Further to this, inadequate supply of food was found to be another possible factor for non-adherence to 
TB treatment. Anti-TB drugs usually makes TB patients feel hungrier and crave more food as such 
inadequate food supply may pose a challenge to treatment adherence (18).  
 
The study also established that side effects of the TB drugs such as feeling weak, dizziness and feeling 
hungry could be another possible factor for non-adherence to TB treatment. These side effects were cited 
as some of the reasons that deter other patients from finishing their course of treatment (23) (24) (26). 
Additionally, other respondents indicated that the TB pills are huge in size which makes it difficult to 
swallow as such most TB patients prefer to skip taking the pills which eventually leads to treatment non-
adherence. 
 
Another possible factor cited by the respondents that prevents TB patients from adhering to treatment was 
the feeling of improvement after starting treatment. The health of some TB patients greatly improve after 
the first few weeks of treatment and as such they stop taking the medication all together thinking that they 
are cured. A number of studies have reported feeling cured as the main reason for treatment non-
adherence and eventual default from treatment (16,18).  
4.2.2. Disclosure of TB status and perception of TB as a disease 
The disclosure of TB status was established to be a minor challenge in our study. The majority of the 
respondents indicated that they are able to disclose their TB status to their relatives and other members of 
the community. Additionally, in all the three villages covered, the FGDs established that people felt that it 
was not shameful to have TB. People in these areas perceived TB just like any other disease. This is 





4.2.3. Use of other treatment options apart from anti-TB drugs 
The study established that some TB patients apart from taking the conventional anti-TB drugs sought 
other treatment options. These other treatment options mainly include the use of herbal medication and 
one particular herbal medication commonly used is “TERAS”. As such some patients opt to use the 
herbal medication instead of the conventional anti-TB drugs. This poses as a challenge to TB treatment 
adherence. These findings are similar to other findings from another study in which the use of herbal 
medication was reported as a risk factor for treatment default (18).  
4.2.4. Support needed by TB patients from relatives, healthy workers and the community 
Since forgetfulness was cited as one of the barriers that prevents TB patients from adhering to treatment, 
most of the respondents indicated that they expect their relatives/family to remind them consistently about 
the dates for drug refill at the healthy facility and also a daily reminder to take their medication.  
Due to the feeling of increased hunger experienced by TB patients on treatment, it was indicated that not 
only do TB patients expect to be supplied with adequate amounts of food by their relatives but also expect 
encouragement to actually take the food. 
 
Healthy workers are expected to give advice on TB and also encourage the TB patients to stick to the 
guidelines for taking their TB medication. Further it was indicated that TB patients expect to be received 
with courtesy at the healthy facility. 
4.2.5. Ways of promoting adherence to TB treatment 
Since the feeling of increased hunger experienced by TB patients was reported as a factor that prevents 
TB patients from adhering to treatment, the provision of food supplements by the government such as: 
Soya, maize flour and cooking oil was cited as one of the major ways of promoting adherence to TB 
treatment. If one has adequate supply of food, they can easily take their TB medication knowing that once 
they feel hungry there will be enough food readily available for them. Further to this, the fact that side 
effects of the anti-TB drugs, one of which includes feeling weak was indicated in our study as one of the 
challenges to TB treatment adherence, it justifies the provision of food supplements by the government 
since in most cases TB patients who are weak cannot afford to work and provide for their families. So 
these patients could really benefit from the provision of these food supplements. 
 
Another way of promoting adherence to TB treatment that was identified was for government to intensify 
public awareness campaign messages about TB and its treatment. This will in turn ensure that people 
have the correct knowledge about TB and its treatment which is key to TB treatment adherence as this 





Availability of anti-TB drugs in all healthy facilities across the country was also identified in our study to 
be one of the ways of promoting adherence to TB treatment. Shortage of anti-TB drugs in some healthy 
facilities is another factor that prevents TB patients from adhering to treatment. Some TB patients travel 
long distances to a healthy facility to collect anti-TB drugs only to be told that the drugs are not available. 
This discourages them and in the long run leads to treatment non-adherence. It is therefore government’s 



























CHAPTER 5. CONCLUSION AND RECOMMENDATIONS 
5.1. INTRODUCTION  
The chapter aims at drawing conclusions from the discussions and analysis of the research findings on 
which basis some recommendations are being advanced. The study aimed to describe socio-cultural and 
behavioral factors affecting adherence to TB treatment in Malawi. The conclusions are made in the frame 
work of the following objectives stated in Chapter One: 
5.2. SUMMARY OF FINDINGS FROM THE STUDY 
5.2.1To describe socio-cultural attitudes with the potential to influence adherence to TB treatment 
among TB patients through the use of focus group discussions (FGDs) 
Alcohol abuse was perceived as a major barrier to TB treatment adherence. It was indicated among the 
respondents that some TB patients miss taking their TB drugs because of recurring use of alcohol. Some 
TB patients are often seen taking beer and as a result they forget to take their medication due to the 
influence of alcohol. This is in line with findings from one study in which the recurring use of alcohol 
was found to be a factor which leads to treatment non-adherence. 
The study also established that side effects of the TB drugs such as feeling weak, dizziness and feeling 
hungry could be another possible factor for non-adherence to TB treatment. Another possible factor cited 
by the respondents that prevents TB patients from adhering to treatment was the feeling of improvement 
after starting treatment. The health of some TB patients greatly improve after the first few weeks of 
treatment and as such they stop taking the medication all together thinking that they are cured. 
5.2.2 To determine TB patients’ knowledge of TB and its treatment through the use of a structured 
questionnaire 
From our study, 77.5% of the respondents had knowledge about TB and 50.0% of them were able to 
mention at least one correct symptom of TB (coughing for over 3 weeks). This display of knowledge can 
be attributed to the fact that almost half of the respondents had attended secondary education (43.0%). 
5.2.3. To identify practices among TB patients with the potential to affect TB treatment adherence 
through the use of a questionnaire 
Since forgetfulness was cited as one of the barriers that prevents TB patients from adhering to treatment, 
most of the respondents indicated that they expect their relatives/family to remind them consistently about 




Due to the feeling of increased hunger experienced by TB patients on treatment, it was indicated that not 
only do TB patients expect to be supplied with adequate amounts of food by their relatives but also expect 
encouragement to actually take the food. 
5.3. CONCLUSION  
The study has established that in general TB patients in Malawi have a good understanding of the disease 
which was demonstrated by their ability to cite symptoms such as “coughing for over 3 weeks”, mode of 
transmission “through the air when coughing” and that TB is contagious but at the same time it is curable.  
Again based on the study findings, it has been established that TB patients who have the correct 
knowledge and accurate information about the disease have low self-stigmatization and in general have a 
good adherence to treatment.  However, the study also established that there are some practices among 
TB patients that have the potential to affect treatment adherence such as alcohol abuse and combining TB 
treatment with other treatment options (herbal medication). 
Patients attitudes towards the disease such as side effects of the TB drugs and feeling of improvement 
after starting treatment were also found to be potential factors to treatment non-adherence. 
It should be stated that TB can lead to devastating effects hence the need for TB patients to take their 
drugs in line with the given guidelines. The study results have clearly shown that though TB medical 
interventions were available but the affected patients were not following appropriate guidelines from the 
health personnel. In addition, other patients would combine the conventional TB treatment with other 
treatment options which posed as a risk factor for treatment non-adherence.  
Tuberculosis is one of the and killer diseases worldwide and Malawi is no exception. Effective treatment 
and a clear understanding of the factors that undermine treatment is required in order to control TB.  
 It is therefore, important for TB patients to follow the prescribed medication and the given instructions 













 There is need for government to provide food supplements such as: Soya, maize flour and 
cooking oil as one of the major ways of promoting adherence to TB treatment. 
 There is need for government to intensify public awareness campaign messages about TB and its 
treatment. This will in turn ensure that people have the correct knowledge about TB and its 
treatment which is important to TB treatment adherence as this study and other previous studies 
have revealed. 
 There is also need for the availability of anti-TB drugs in all healthy facilities across the country 
as it was identified in our study to be one of the ways of promoting adherence to TB treatment. 
Shortage of anti-TB drugs in some healthy facilities is another factor that prevents TB patients 
from adhering to treatment. Some TB patients travel long distances to a healthy facility to collect 
anti-TB drugs only to be told that the drugs are not available. 
 There is also need for friends and families to remind and encourage the relatives suffering from 
TB to take their medication and also remind them when they are supposed to visit the healthy 
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APPENDIX 1  
QUESTIONNAIRE (English version) 
 SOCIO-CULTURAL AND BEHAVIORAL FACTORS AFFECTING ADHERENCE TO TB 
TREATMENT IN MALAWI 
1. ID……….                              
2. Age 
       3.  Gender 
a. Male   b. Female 
4. Occupation  
a. Farmer    b. Fisherman/woman 
c. Business    d. Schooling  
e. Others (Specify) ___________________________________   
5. Education level. 
a. None   b. Standard 1-4  c. Standard 5-8 
d. Form 1-2 e. Form 3-4  f. Tertiary 
6. Marital Status  
a. Single  b. Married c. Widowed  
     d. divorced e. Separated 




8. If yes, from which source? 
a. From friends/relatives/workmates 




f. Booklet  
g. Other (specify)………………………….. 
9. What symptoms can show that a person has TB? 
a. Coughing with sputum 
b. Coughing for over 3 weeks 
c. Periodic increases of temperature for over 3 weeks 
d. Blood in sputum 
e. Loss of appetite 
f. Night sweating 
g. Pain in the chest 
h. Total weakness 
i. Weight loss 




10. Is TB contagious? YES…. NO……. DON’ T KNOW…… 
11.  How is TB transmitted? 
a. Through the air when coughing 
b. Through blood 
c. Through handshake with an infected person 
d. Sexually transmitted 
e. Sharing food with an infected person 
f. You’re born with it 
g. I don’t know 
h. Other (specify)…………………………………… 
12. Is TB curable? YES…... NO……. DON’ T KNOW….. 
13. Do you take your TB medication according to guidelines? YES…. NO…. 
14. If no, what are some of the challenges/barriers that prevent you from adhering to your 
medication?  
15. Have you disclosed or did you disclose your TB status to others? YES… NO….  
16. If NO to question 15, why not? 
a. Because I will lose Job 
b. Because I will lose friends 




d. Because no one will marry me 
e. Other (specify)………………………………………. 
17. Do you think it is shameful to have TB? YES…. NO…… DON’T KNOW….. 
18. If yes, why? ………………………………….. 
19. What other treatment options have you sought apart from taking Anti-TB drugs? 
20. Is it a common practice to combine TB medication with other treatment options?  
21. What support do you think TB patients need from health workers, relatives and the community? 




















FOCUS GROUP DISCUSSION (FGD) GUIDE (English version) 
(Please record the following details for each FGD) 
Name of Interviewer ……………………………………………  
Name of Recorder/Note taker …………………………………. 
Date of Interview …………………………………………...  
Start Time  ……………………...   Finish Time ………... 
District ………………………   TA ………………… 
GVH  ……………………....  VG ………………… 
Number of People Interviewed (Men) ………. (Women)…………     
 (Boys) ………. (Girls)…………….. 
Estimated ages   (ranging from … to …) 
Estimated education levels (ranging from … to …) 
INTRODUCTION 
Hello everyone. My name is ______, and my colleague’s name is _____. I am a student at the university 
of Kwazulu Natal in South Africa and I am conducting a research on socio-cultural and behavioral factors 
affecting adherence to TB treatment in Malawi. In this research I want to hear from you about TB 
treatment adherence issues. I would like to remind you that we want your honest explanation of how you 
see, feel about and understand the issues that we will be discussing. It is also imperative that you give us 
honest responses even if you feel that some people may not agree with them. We want everyone to feel 




are making your contribution. Also, I want to tell you that what you say here will be kept confidential. No 
one outside the group will know what you personally said. I will be guiding the discussions and would 
like to begin by asking some general questions. We will be writing down what is said although we won’t 
write your names down. Everything you say will be anonymous. We will talk for about an hour. 
 QUESTIONS   
1. Do people in this community take their TB medication according to guidelines?  
2. If not, what are some of the challenges/barriers that prevent people from adhering to their 
medication?  
3. Has anyone in the group disclosed or did anyone disclose their TB status to others?  
4. If not, what are some of the reasons that prevent people from disclosing their TB status? 
5. In this community do people view TB as a shameful disease?  
6. Why do you think people might feel this way? 
7. What other treatment options have people in this community sought apart from taking Anti-TB 
drugs? 
8. Is it a common practice to combine TB medication with other treatment options? 
9. In this community what support do people think TB patients need from health workers as far as 
TB treatment adherence is concerned? 
10. What support do people think TB patients need from relatives and the community? 










PARTICIPANT INFORMATION LEAFLET AND CONSENT FORM (English version) 
TITLE OF THE RESEARCH PROJECT: Socio-Cultural and Behavioral factors affecting adherence 
to TB treatment in Malawi by Ruth Lipato. Funded by University of Kwazulu Natal, Durban South 
Africa.  
PRINCIPAL INVESTIGATOR: Ruth Lipato  
ADDRESS: P.O. Box 45, Mulanje, Malawi  
CONTACT NUMBER: 00 265 995 500 657  
You are being invited to take part in a research project. Please take some time to read the information 
presented here, which will explain the details of this project. Please ask the study staff any questions 
about any part of this project that you do not fully understand. It is very important that you are fully 
satisfied that you clearly understand what this research entails and how you could be involved. Also, your 
participation is entirely voluntary and you are free to decline to participate. If you say no, this will not 
affect you negatively in any way whatsoever. You are also free to withdraw from the study at any point, 
even if you do agree to take part.  
This study has been approved by the College of Medicine Research and Ethics Committee and will be 
conducted according to the ethical guidelines and principles of the international Declaration of Helsinki, 
Malawi Guidelines for Good Clinical Practice.  
What is this research study all about?  
 This study will be conducted at Bwaila Hospital  
 This study is aimed at exploration of:  
 Socio-Cultural and Behavioral factors affecting adherence to TB treatment in Malawi. 
 No names of the participants will be recorded.  
Why have you been invited to participate?  
You have been asked to participate in this study because you were diagnosed with TB and currently you 
are on TB treatment. 
What will your responsibilities be?  
Your responsibility is to respond as honestly as possible to all the questions that will be administered to 
you through the questionnaire. 
Will you benefit from taking part in this research?  
You will not receive any payment for participating in this study. Participants will benefit from the 
information gathered in this Study because it will help identify ways that would maximize adherence 
levels to TB treatment hence reducing the development of drug resistance and the spread of TB in 






Are there any risks involved in your taking part in this research?  
There are no risks involved in taking part in this research  
If you do not agree to take part, what alternatives do you have?  
You are free to decline not to take part in this study. Nothing will happen to you if you decide to decline.  
Who will have access to the records of the data?  
The data will be kept confidential. Only the investigators in this study will have access to the data. When 
the data is published, we will not use names or any other information that may lead to readers identifying 
you.  
What will happen in the unlikely event of some form of injury occurring as a direct result of your 
taking part in this research study?  
If due to your participation in this study you suffer any injury, we will refer you to a relevant/appropriate 
professional for assistance.  
Will you be paid to take part in this study and are there any costs involved?  
No you will not be paid to take part in the study. There will be no costs involved for you, if you do take 
part.  
Is there anything else that you should know or do?  
You can contact Ruth Lipato at cell: 0995 500 657 if you have any further queries or encounter any 
problems.  
You can contact the Secretariat of College of Medicine Research and Ethics Committee at 0111871 911 
EXT 334 if you have any concerns or complaints that have not been adequately addressed by the study 
staff.  
You will receive a copy of this information and consent form for your own records.  
Declaration by participant  
By signing below, I ………………………………….…………. agree to take part in a research study 
entitled (Socio-Cultural and Behavioral factors affecting adherence to TB treatment in Malawi)  
I declare that:  
 I have read or had read to me this information and consent form and it is written in a language with 
which I am fluent and comfortable.  
 I have had a chance to ask questions and all my questions have been adequately answered.  
 I understand that taking part in this study is voluntary and I have not been pressurized to take part.  
 I may choose to leave the study at any time and will not be penalized or prejudiced in any way.  
 I may be asked to leave the study before it has finished, if the study researcher feels it is in my best 
interests, or if I do not follow the study plan, as agreed to.  
 
Signed at (place) ......................…........……………. on (date) …………....………... 2016.  
Signature of participant                                Signature of witness  
……………………………………………… …………………………………………..  
Finger print of participant                            Finger print of witness  
Declaration by investigator  
I (name) ……………………………………………...……… declare that:  
 I explained the information in this document to …………………………………...  
 I encouraged him/her to ask questions and took adequate time to answer them.  
 I am satisfied that he/she adequately understands all aspects of the research, as discussed above  
 I did/did not use a interpreter. (If a interpreter is used then the interpreter must sign the declaration 
below.  
 
Signed at (place) ......................…........……………... on (date) …………....………... 2016.  






QUESTIONNAIRE (Chichewa version) 
SOCIAL BEHAVIORAL FACTORS AFFECTING ADHERENCE TO TB TREATMENT IN 
MALAWI 
1. ID……….                              
2. Age……… 
       3.  Gender 
b. Male   b. Female 
 
4. Occupation  
a. Farmer    b. Fisherman/woman 
d. Business    d. Schooling  
e. Others (Specify) ___________________________________   
5. Education level. 
a. None   b. Standard 1-4  c. Standard 5-8 
d. Form 1-2 e. Form 3-4  f. Tertiary 
6. Marital Status  
a. Single  b. Married c. Widowed  
     d. divorced e. Separated 
7. Musanapezeke ndi nthenda ya chifuwa chachikulu, mudayamba mwamvapo za nthenda 
imeneyi? 
8. Ngati mudayamba mwamvapo, mudamva kuchokela kuti? 
a. Kwa amzanga/abale/ogwila nawo ntchito 
b. Kwa ogwila ntchito za umoyo 
c. Mu nyuzipepala 
d. Pa wailesi 





g. Other  
9. Kodi ndi zizindikilo ziti zomwe zingawonetse kuti munthu ali ndi chifuwa chachikulu? 
a. Kutsokomola makhololo 
b. Kutsokomola kudutsa masabata atatu 
c. Kutentha thupi kudutsa masabata atatu 
d. Kutsokomola magazi 
e. Kusafuna chakudya 
f. Kutuluka thukuta usiku 
g. Kupweteka mu chifuwa 
h. Kufooka 
i. Kuchepa thupi 
j. Other  
10. Kodi chifuwa chachikulu mutha kupatsilana? 
11. Kodi chifuwa chachikulu chimafalikila bwanji? 
a. Kupyolera mumpweya potsokomola 
b. Kupyolera mmagazi 
c. Popatsana moni wa padzanja ndi munthu yemwe ali ndi chifuwa chachikulu 
d. Pogonana 
e. Kudyela limodzi chakudya ndi munthu yemwe ali ndi chifuwa chachikulu 
f. Umabadwa nayo 
g. Sindikudziwa 
h. Other  
12. Kodi chifuwa chachikulu ndichochizika? 
13. Kodi mumamwa mankhwala anu a chifuwa chachikulu motsatila ndondomeko? 
14. Ngati simutero, tiuzeni zina mwazokhoma zomwe zimakukanikitsani kumwa mankwala anu 
motsata ndondomeko 
15. Kodi mudawulula kwa anthu kuti adakupezani ndi chifuwa chachikulu? 
16. Ngati simudawulule tiuzeni zina mwa zifukwa zomwe simudawululire 
a. Kuwopa kuti andichotsa ntchito 
b. Kuwopa kuti amzanga andithawa 
c. Kuwopa kusalidwa ndi anthu 
d. Kuwopa kuti ndingasowe banja 
e. Other  
17. Kodi mukuganiza kuti ndizochititsa manyazi kupezeka ndi chifuwa chachikulu? 




19. Kupatula mankhwala a kuchipatala omwe mukumwa, mwayesapo njila zina zothetsela chifuwa 
chachikulu? 
20. Kodi ndizotchuka kuphatikiza mankhwala achifuwa chachikulu akuchipatala ndi njila zina 
zothetsa chifuwa chachikulu? 
21. Kodi ndi thandizo lanji lomwe anthu odwala chifuwa chachikulu akulisowa kuchokela kwa 
ogwila ntchito za umoyo, achibale komanso anthu a mmudzi? 
22. Kodi mukuganiza kuti boma likuyenela kupangapo chani pofuna kupititsa patsogolo 

























FGD GUIDE (Chichewa version) 
(Please record the following details for each FGD) 
Name of Interviewer ……………………………………………  
Name of Recorder/Note taker …………………………………. 
Date of Interview …………………………………………...  
Start Time  …………………….   Finish Time ………. 
District ………………………   TA ………………… 
GVH  ……………………....  VG ………………… 
Number of People Interviewed (Men) ………. (Women)…………     
 (Boys) ………. (Girls)……………. 
Estimated ages   (ranging from … to …) 
Estimated education levels (ranging from … to …)     
MALONJE 
Moni nonse. Dzina langa ndi Ruth Lipato ndipo amzangawa dzina lawo ndi 
…………………………………. Ndine mmodzi mwa ophunzila pa sukulu ya za ukachenjede ku 
University of Kwazulu Natal ku South Africa. Ndikupanga kafukufuku yemwe tikuyang’ana zina 
mwazifukwa zimene zimapangitsa anthu odwala chifuwa chachikulu kuti asamatsatile ndondomeko 
yakamwedwe ka mankwala kuno kwathu ku Malawi. ndikufuna ndikukumbutseni kuti tifuna mayankho 
anu achilungamo pa mmene mukuwonela komanso kumvela pa nkhani imeneyi. Komanso nkofunika kuti 
mutipatse mayankho owona okhaokha ngakhale mukuwona kuti anzanu sakugwilizana nazo. Tikufuna 
aliyense akhale omasuka kunena zomwe akuganiza ngakhale ena asakuganiza chomwecho. Chonde 
lankhulani mokweza pamene mukupeleka mfundo zanu. Komanso ndikufuna ndikutsimikizileni kuti 
zones zomwe mulankhule pano zizasungidwa mwachinsinsi. Palibe wapambali yemwe akadziwe zomwe 
mwanena. Ndikhala ndikutsogolera zokambilana zathu ndipo ndikufuna ndiyambe ndikufunsa mafunso 
apo ndi apo. Tizilemba zokambilana zathu ngakhale pazolembapo sipalembedwa dzina la munthu. 








1. Kodi anthu mdera lino amamwa mankhwala awo a chifuwa chachikulu motsatila ndondomeko? 
2. Ngati sichoncho, zina mwazifukwa zomwe zimalepheletsa anthu kutsatila ndondomeko ya 
kamwedwe ka mankwala ndi chani/ 
3. Kodi alipo mgulu mwathumu yemwe adawululapopo kwa ena kuti ali ndi chifuwa chachikulu? 
4. Ngati sichoncho, zina mwazifukwa zomwe zimalepheletsa anthu kuwulula ndi ziti? 
5. Kodi mdela lino anthu amachitenga chifuwa chachikulu ngati nthenda yochititsa manyazi? 
6. Mukuwona ngati anthu amaganiza choncho chifukwa chani? 
7. Kodi mdela lino ndi chithandizo chanji chomwe anthu amafunafuna pambali pomwa mankhwala 
a chifuwa chachikulu? 
8. Kodi mchitidwe ophatikiza mankhwala a chifuwa chachikulu ndi zithandizo zina ndiwotchuka 
mdela lino? 
9. Kodi mukuganiza kuti ndi chithandizo chanji chomwe anthu odwala chifuwa chachikulu 
amayembekeza kuchokela kwa anthu ogwila ntchito za umuyo pankhani yokhudza ndondomeko 
ya kamwedwe ka mankhwala? 
10. Nanga mukuganiza kuti ndi chithandizo chanji chomwe anthu odwala chifuwa chachikulu 
amachisowa kuchokela kwa abale awo komanso anthu a mdela lawo? 
11. Kodi mukuganiza kuti boma lingathe kuchitapo chani pofuna kupititsa patsogolo kutsatila 
ndondomeko ya kamwedwe ka mankhwala? 
 
 
 
